Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04875585
Title Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC (INNWOP1)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University Innsbruck
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUT

Facility Status City State Zip Country Details
Medical University Innsbruck RECRUITING Innsbruck Tirol 6020 Austria Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field